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Abstract A randomised clinical trial in primary care with a
12-months follow-up period. About 135 patients with acute
sciatica (recruited from May 2003 to November 2004) were
randomised in two groups: (1) the intervention group
received physical therapy (PT) added to the general practi-
tioners’ care, and (2) the control group with general
practitioners’ care only. To assess the effectiveness of PT
additional to general practitioners’ care compared to general
practitioners’ care alone, in patients with acute sciatica.
There is a lack of knowledge concerning the effectiveness of
PT in patients with sciatica. The primary outcome was
patients’ global perceived effect (GPE). Secondary
outcomes were severity of leg and back pain, severity of
disability, general health and absence from work. The out-
comes were measured at 3, 6, 12 and 52 weeks after
randomisation. At 3 months follow-up, 70% of the inter-
vention group and 62% of the control group reported
improvement (RR 1.1; 95% CI 0.9–1.5). At 12 months fol-
low-up, 79% of the intervention group and 56% of the control
group reported improvement (RR 1.4; 95% CI 1.1; 1.8). No
significant differences regarding leg pain, functional status,
fear of movement and health status were found at short-term
or long-term follow-up. At 12 months follow-up, evidence
was found that PT added to general practitioners’ care is only
more effective regarding GPE, and not more cost-effective in
the treatment of patients with acute sciatica than general
practitioners’ care alone. There are indications that PT is
especially effective regarding GPE in patients reporting
severe disability at presentation.
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Introduction
The lumbosacral radicular syndrome (LRS), also called
sciatica, is a disorder with radiating pain in the leg below
the knee in one or more lumbar or sacral dermatomes, and
can be accompanied by phenomena associated with nerve
root tension or neurological deficits [18, 21, 22, 28]. A
prolapsed disc is a frequent cause of LRS, but other causes
include spinal or lateral recess stenosis, tumours and
radiculitis [7, 21, 22, 28]. The incidence of LRS in the
Netherlands is estimated at 5 per 1,000 persons a year [7].
There is consensus that treatment of LRS in the first
6–8 weeks should be conservative. The exact content of the
P. A. J. Luijsterburg (&)  A. P. Verhagen  B. W. Koes
Department of General Practice, Erasmus MC, PO Box 2040,
3000 CA Rotterdam, The Netherlands
e-mail: pimluijsterburg@home.nl
R. W. J. G. Ostelo
VU, Institute for Research in Extramural Medicine,
Amsterdam, The Netherlands
R. W. J. G. Ostelo
Amsterdam School of Allied Health Education,
Amsterdam, The Netherlands
H. J. M. M. van den Hoogen
General Practice, Asten, The Netherlands
W. C. Peul
Neurosurgery, Leids University Medical Center,
Leiden, The Netherlands
W. C. Peul
Neurosurgery, Medical Center Haaglanden,
Den Haag, The Netherlands
C. J. J. Avezaat
Neurosurgery, Erasmus MC, Rotterdam, The Netherlands
123
Eur Spine J (2008) 17:509–517
DOI 10.1007/s00586-007-0569-6
conservative treatment is, however not yet clear [25]. After
the study of Vroomen et al. [26] bed rest is no longer regarded
as a treatment option for LRS [16]. Assessed in a recent
systematic review was the effectiveness of conservative
treatments of LRS [15]. Thirty trials were included that
evaluated injections (n = 14), traction (n = 9), physical
therapy (PT) (n = 4), bed rest (n = 2), manipulation
(n = 2), medication (n = 2) and acupuncture (n = 1) as a
treatment for LRS. Because several trials indicated no evi-
dence of an effect it is not recommended to use corticosteroid
injections and traction as treatment option. Whether clini-
cians should prescribe PT, bed rest, manipulation or
medication could not be concluded from this review.
Therefore, there is no evidence that one type of conservative
treatment is clearly superior to others for patients with LRS.
In an previous observational study it was shown that
GPs did not adhere to the guideline regarding the referral to
PT; almost half of patients with LRS were referred for PT,
although this was not recommended in the guideline. No
specific characteristic could be identified to explain this
referral to PT [13]. Moreover, there is a lack of knowledge
concerning the effectiveness of PT in LRS [15]. Therefore,
this study aimed to assess the effectiveness of PT man-
agement additional to GP management compared to GP
management alone, in patients with acute LRS.
Methods
More detailed information about the methods of the LRS
trial is presented elsewhere [14]. The Erasmus Medical
Center Ethics Committee approved the procedures and
design of this trial.
Study population
Participating GPs in Rotterdam and the surrounding area
invited patients with acute LRS to participate in the trial
from May 2003 to November 2004. The GPs were invited
by mail to participate in the trial. Table 1 shows the eli-
gibility criteria.
The trial attempted to enrol 182 patients with LRS, 91
patients in both treatment groups. This sample size was
regarded sufficient to detect a difference of 20% (with a a of
0.05 and a power of 80%) in the primary outcome Global
Perceived Effect (GPE) between the two treatment groups.
Randomisation
A concealed randomisation procedure [14] was used,
which was based on a computer-generated randomisation
list developed by an independent person. Concealment was
ensured because patients’ unique trial number was typed in
a special database, which was not editable for the research
assistant and a second randomisation action using the same
trial number was not possible. Hereafter, the random
allocation appeared on screen. In order to prevent unequal
treatment group sizes, block randomisation was used with
blocks of ten patients [19]. This means that after every
tenth patient the number of patients allocated to both
treatment groups was equal. The research assistant per-
formed the randomisation after baseline measurement.
Blinding
For obvious reasons the GPs, physical therapists and
patients were not blinded for treatment allocation. The
statistical analysis and interpretation of the findings was
audited and verified by an independent statistician.
GP care
All patients were treated by the GP according to their
clinical guideline [21]. GPs gave information and advice
about LRS and, if necessary, prescribed (pain) medication
(see Fig. 1).
Table 1 Selection criteria for trial eligibility
Inclusion
Radiating (pain) complaints in the leg below the knee
Severity of complaints scored above 3 on an 11-point NRS
(0 = no complaints; 10 = maximum complaints)
Duration of the (pain) complaints \6 weeks
Age between 18 and 65 years
Able to speak and read Dutch
Presence of one of the following symptoms
More pain on coughing, sneezing or straining
Decreased muscle strength in the leg
Sensory deficits in the leg
Decreased reflex activity in the leg
Positive straight leg raising test
Exclusion
Radiating (pain) complaints in the preceding 6 months
Back surgery in the past 3 years
Treated with epidural injections
Pregnancy
Co-morbidity that determines overall well-being
Direct indication for surgery (unbearable pain,
fast progression of paresis or cauda equina syndrome)
Expected loss to follow-up (i.e. moving to another
part of the country, long-lasting foreign holiday)
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Physical therapy
Physical therapy treatment consists of exercise therapy as
well as giving information and advice about LRS. Passive
modalities such as massage and manipulation techniques,
or applications such as ultrasound therapy or electrotherapy
were not allowed. The treatment protocol was developed in
a consensus meeting with participating physical therapists.
They acted as coaches and guided the patient in order to
stimulate return to activity (type/content of the exercises
was left to the expertise of the participating physical
therapists), despite the pain experience. Both GP and PT
interventions (only in an one to one setting; group settings
were not allowed) were restricted to a maximum of nine
treatments/consultations in the first 6 weeks after
randomisation.
Measurements
Collected at baseline were patients’ characteristics such as
gender and date of birth. Standardised history taking was
used to establish whether patients were familiar with LRS
in the past, reported more pain in the leg on coughing/
sneezing or straining, on sitting, standing, walking and
lying down and whether patients reported decreased mus-
cle strength and sensory deficits in the leg. The physical
examination included amongst others the straight leg rais-
ing test and the test of Bragard [9]. The primary outcome
and most of the secondary outcomes were scored by the
patients. At 3, 6, 12 and 52 weeks follow up the patients
received a questionnaire by mail.
These questionnaires also measured absence from work
due to LRS (in days) and medical consumption (i.e. medi-
cation use, additional therapies, visits to GP, PT or
specialists).
Primary outcome measure
The primary outcome measure was the GPE, measured
on a seven-point scale ranging from 1 = completely
recovered to 7 = vastly worsened [1, 2, 6]. These ratings
were dichotomised as improved (‘completely recovered’
and ‘much improved’), versus not improved (‘slightly
improved’, ‘not changed’, ‘slightly worsened’, ‘much
worsened’ and ‘worse than ever’).
Secondary outcome measures
Pain severity of the leg and the back was scored separately
on an 11-point numerical rating scale (NRS) ranging from
0 = no pain to 10 = unbearable pain [24]. The functional
Definition: The lumbosacral radicular syndrome: radiating pain and/or neurological deficits in one or more lumbar or 
sacral dermatomes, often associated with back pain; mostly caused by irritation and compression (traction) of the nerve 
root.
History taking: Ask about: 1) localisation, radiation, intensity and duration of the pain, 2) influence of rest, movement 
and posture, 3) development of the complaints, 4) interference with daily activities caused by leg pain, 5) decreased 
muscle strength and sensory deficits, 6) influence of coughing, sneezing or straining, 7) previous history of back 
complaints, and 8) urinary problems and saddle anaesthesia. 
Physical examination: 1) physical inspection (spine and pelvis), 2) active examination (ante-, retro-, lateroflexion), and 
3) Lasègue sign and test of Bragard. If there is a positive Lasègue sign, decreased muscle strength or sensory deficits  
perform: 4) ankle tendon reflex and knee tendon reflex, 5) sensory examination of the lateral and medial side of the 
foot, 6) muscular strength of the big toe, walking on heels and toes, and 7) crossed test of Lasègue.  
Additional examinations: X-rays should only be ordered in case of suspicion on malignancy or a fracture due to 
osteoporosis.
Evaluation: The lumbosacral radicular syndrome should be diagnosed if there are radiating complaints in the leg below 
the knee, plus one of the following findings: 1) a positive Lasègue sign (or Bragard), or 2) neurological deficits  
reducible to a single nerve root. 
Information and advice: Explain to the patient that radiating complaints are caused by a prolapsed disc that gives 
pressure on a nerve in the back. There is a favourable coursein 80% of the patients with conservative care. Back pain  
may persist after the leg pain has gone. 
Advice the patient to perform the usual daily activities but to avoid painful movements. Gradually increase the  
activities. Gradually increase the activities to normal level in six weeks and to patients’ level in six to twelve weeks.  
Follow-up: Evaluate the effect of treatment by checking Lasègue sign and the severity of the complaints. Check 
patients with severe complaints daily and subsequently at least once a week. Accompany the patient till full resumption  
of daily activities. 
Drug treatment: If desired: paracetamol (4-6 dd, 500mg), ibuprofen (3-4 dd, 400 mg), diclofenac (3-4 dd, 25-50 mg), or 
naproxen (2-3 dd, 250 mg). 
Referral: Refer in an instant: 1) cauda equina syndrome, or 2) progressive paresis within a few days in spite of 
conservative care. Refer for diagnostics and judgement for indication for surgery: 1) Severe radicular pain in spite of 
bed rest and adequate medication, 2) Severe paresis or progressive paresis in spite of adequate care (walking on heels 
and toes is impossible), 3) doubtful diagnosis, or 4) mild complaints with no improvement after six to eight weeks. 
Fig. 1 Summary of the clinical
guideline ‘Lumbosacral
radicular syndrome’ of the
Dutch College of General
Practitioners (1996)
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status was measured with the Roland Morris Disability
Questionnaire (RDQ) for sciatica [20].
Health status was measured by the 36-item short form
(SF-36) [27] and the Euroqol (EQ-5D) instrument [4, 5].
Fear of movement was measured by the Tampa scale for
kinesiophobia (TSK) [10, 23]. LRS-related absence from
work (in days) and medical consumption were measured by
means of a questionnaire.
Statistical analysis
The statistical analysis was performed according to the
intention-to-treat principle, analysing all patients in the
treatment group to which they were randomly allocated.
Baseline comparability was investigated by descriptive
statistics to examine whether randomisation was success-
ful. Missing (item) values were assigned the last available
score. Group differences and 95% confidence intervals (CI)
were calculated for all outcome measures with a baseline
value. Between group differences were calculated using the
Student’s t-test for continuous variables and the Chi-square
test for dichotomous variables. Results are presented as
relative risks (RR) or effect sizes (ES) with corresponding
95% CI.
Also presented is the number needed to treat, i.e. the
number of patients that needs to be treated, resulting in one
more ‘improved’ patient in the ‘GP + PT care’ group
compared to the ‘GP care only’ group. There was a sta-
tistically significant difference if the P-value was smaller
than 0.05, and a clinically relevant difference when a 20%
difference appeared in one of the outcome measurements
between both groups. In addition a per-protocol analysis
was performed, analysing only those patients with no
serious treatment protocol deviations, e.g. received the
allocated treatment. Pre-determined subgroup analyses
were performed for patients with severe disability (RDQ
C 17). Supplementary analysis were performed with multi-
variate regression to examine the possibility of confound-
ing. The baseline values of variables were used as
covariates in the main analyses, whenever appropriate, to
adjust for possible differences between the randomised
groups.
Results
Study population
In total 112 GPs participated in the trial and referred 170
patients for eligibility check. Excluded from the trial were
35 patients for one or more of the following reasons; 16
patients did not want to participate, 1 patient was older than
65 years, 7 patients had (pain) complaints for more than
6 weeks, 3 patients had no radiating (pain) complaints in
the leg below the knee, 5 patients were not available for
follow-up measurements, 3 patients had back surgery in the
past 3 years, 1 patient had received an epidural injection, 7
patients were already treated by a PT and 2 patients were
pregnant.
Included and randomised were 135 patients, 67 patients
received GP plus PT care (the intervention group) and 68
patients received GP care only (the control group). Four
patients dropped-out immediately after randomisation
because they no longer wished to participate, one in the
intervention group and three in the control group. Figure 2
shows the flow chart of the trial.
Characteristics of the study population
Table 2 gives the demographic and clinical characteristics
of the randomised patients. The two groups were consid-
ered comparable for all measured baseline characteristics.
Interventions
At 6 weeks follow-up, the 67 patients of the intervention
group and 68 patients of the control group reported a mean
GP consult of, respectively, 1.1 (SD 1.5) and 1.7 (SD 1.8),
since baseline.
The mean GP consult at 12 and 52 weeks follow-up
was, respectively, 1.6 (SD 1.4) and 1.8 (SD 1.9) in the
intervention group and, respectively, 1.9 (SD 2.1) and 2.2
(SD 2.7) in the control group. These differences were not
significant. At baseline, the GPs had prescribed NSAIDs,
opioids and muscle relaxants for, respectively, 47, 8 and 23
patients in the intervention group, and for, respectively, 40,
10 and 15 patients in the control group.
Patients in the intervention group were treated by 33
different physical therapists. The number of treated patients
per physical therapist ranged from 1 to 9. Patients in the
intervention group reported a mean of 6.7 (SD: 2.9) PT
treatments of at 6 weeks follow-up, and 9.7 (SD 4.7) at
12 weeks follow-up. The mean time between randomisa-
tion and the first PT treatment was 4.6 days (SD 3.1). The
physical therapists reported that during the first treatment
60% (range 10–100%) of the time was spent on history
taking and physical examination, 30% (range 0–60%) on
giving information and advice about LRS, and 10% (range
0–40%) on active exercise therapy (duration of one treat-
ment session was 30 min). During the second through ninth
treatment, 33% (range 0–100%) of the time was spent on
giving information and advice, and 67% (range 0–100%)
on active exercise therapy.
512 Eur Spine J (2008) 17:509–517
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Outcomes
In both groups patients improved over time. At 3, 6 and
12 weeks after baseline there was no significant difference
between the two groups on the primary outcome: GPE
(Table 3). However, at these follow-up moments the
intervention group showed a higher proportion of
‘improved’ patients.
At 52 weeks after baseline there was a significant and a
clinical difference between the groups on the primary out-
come measure GPE, in favour of the intervention group
(Table 3). About 53 patients (79%) in the intervention group
versus 38 patients (56%) in the control group reported to be
‘improved’ (RR, 1.4; 95% CI: 1.1; 1.8 and NNT: 4).
There were no significant differences between the
groups in most of the secondary outcomes at 3, 6, 12 and
52 weeks after baseline (Table 4).
At 12 and 52 weeks follow-up the mean improvement
on leg pain was clinically relevant in both groups;
respectively, 3.9 and 4.4 points for the intervention group
and, respectively, 3.7 and 3.7 points for the control group.
The mean improvement on disability (RDQ) was also
clinically relevant at 12 and 52 weeks follow-up in both
groups; respectively, 7.7 and 10.0 points for the interven-
tion group and, respectively, 8.5 and 9.1 points for the
control group.
The supplementary analyses in which the baseline
values were used as covariates, to adjust for possible
*: Last value carried forward is performed for missing values at each follow-up measurement; these include the drop-
outs (1 in the intervention group and 3 in the control group) direct after randomisation plus the number of patients in 
which some or more data was lacking at each follow-up moment. 
Fig. 2 Flow chart of the trial
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differences between the randomised groups showed no
changes in the reported results.
There were no significant differences between both
groups in the number of patients reporting absence from
work or reported days absence from work. At 12 weeks
follow-up, 36 patients (54%) in the intervention group and
25 patients (37%) in the control group reported a mean of,
respectively, 16.2 days (SD 21.3) and 13.1 days (SD 24.1)
absence from work. At 52 weeks follow-up, 30 patients
(45%) in the intervention group and 25 patients (37%) in
the control group reported, over the whole year, a mean of,
respectively, 29.2 days (SD 48.4) and 28.9 days (SD 72.3)
absence from work.
Co-interventions
In the 52 weeks after baseline 11 patients (16%) in the
intervention group and 6 patients (9%) in the control group
visited a neurologist. In the intervention group four patients
visited a neurosurgeon, one patient a orthopaedist and four
patients (6%) received surgery due to LRS.
In the control group six patients visited a neurosurgeon,
two patients a orthopaedist and three patients (4%)
received surgery. There were a few co-interventions (i.e.
occupational physician) in both groups, but there were no
significant differences between the two groups.
Per-protocol analysis
The per-protocol analysis (the patients that received the
allocated treatment according randomisation) was restric-
ted to 66 patients in the intervention group and 55 patients
in the control group. One patient in the intervention group
had not received PT care and 12 patients in the control
group were treated by PT. Restricting the analysis to the
Table 2 Baseline
characteristics of the 135
patients randomised in two
treatment groups
a NRS Numerical Rating Scale.
Score range from 0 (no pain) to
10 (unbearable pain)
b RDQ Roland disability
questionnaire. Score range from
0 (no disability) to 24 (severe
disability)
c TSK Tampa scale for
kinesiophobia. Scores ranges
from 17 to 68 points; higher
score indicates more
kinesiophobia
Characteristics GP + PT
care (n = 67)
GP care
only (n = 68)
Female gender, n (%) 38 (57) 27 (40)
Age in years, mean (SD) 42 (10) 43 (12)
Paid job, n (%) 48 (72) 50 (74)
Reporting sickness absence, n (%) 34 (51) 32 (47)
Sickness absence from onset in days, mean (SD) 3.1 (4.9) 4.2 (6.8)
Time between onset LRS and baseline in days, mean (SD) 12.1 (10.1) 14.2 (10.2)
Never LRS in past, n (%) 49 (73) 54 (79)
More pain in leg on coughing, sneezing or straining, n (%) 40 (60) 37 (54)
Decreased muscle strength in the leg, n (%) 48 (72) 44 (65)
Sensory deficits in the leg, n (%) 54 (81) 53 (78)
Positive straight leg raising test, n (%) 37 (55) 35 (52)
Positive test of Bragard, n (%) 25 (37) 23 (34)
Taking medication, n (%) 58 (87) 48 (71)
Leg pain on NRSa, mean (SD) 6.3 (2.2) 6.3 (2.2)
Back pain on NRS, mean (SD) 5.8 (2.8) 5.7 (2.5)
RDQb score, mean (SD) 15.9 (4.1) 15.4 (5.0)
TSKc score, mean (SD) 39.0 (5.8) 41.0 (7.1)
Table 3 Data on treatment results at 3, 6, 12 and 52 weeks after baseline: primary outcome
Global perceived effecta GP + PT care GP care only RR (95% CI) NNT
Improved n = 67 (%) Improved n = 68 (%)
Three weeks after baseline 30 (45) 22 (32) 1.4 (0.9; 2.1) 8
Six weeks after baseline 38 (60) 30 (44) 1.3 (0.9; 1.8) 8
Twelve weeks after baseline 47 (70) 42 (62) 1.1 (0.9; 1.5) 12
Fifty-two weeks after baseline 53 (79) 38 (56) 1.4 (1.1; 1.8) 4
a Ratings on patient’s globally perceived effect on a seven-point scale were dichotomised (see Methods section)
RR Relative risk, CI Confidence interval, NNT Number needed to treat, i.e. the number of patients that needs to betreated, resulting in one more
‘improved’ patient in the ‘GP + PT care’ group compared to the ‘GP care only’ group
514 Eur Spine J (2008) 17:509–517
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‘per-protocol’ patients did not change the within group and
between group differences in any substantial way.
Subgroup analysis
The subgroup with severe disability (RDQ C 17) consisted
of 67 patients. The intervention group (n = 37) and the
control group (n = 30) were considered comparable for all
measured baseline characteristics. At 12 and 52 weeks fol-
low-up, respectively, 29 (78%) and 31 (84%) patients with
severe disability in the intervention group and 15 (50%) and
16 (53%) patients in the control group reported to be
‘improved’ (12 and 52 weeks: RR, 1.6; 95% CI, 1.1; 2.3);
indicating a significant and a clinically relevant difference.
Discussion
At 12 weeks after baseline there was no significant dif-
ference between both groups on the primary outcome, but
most of the patients (70% in the intervention group and
62% in the control group) reported to be ‘improved’. At
52 weeks follow-up there was a significant (RR, 1.4; 95%
CI, 1.1; 1.8) and clinically relevant difference (23%)
between both groups, in favour of the intervention group.
However, no significant relevant differences were found in
the secondary outcomes: leg pain, functional status, fear of
movement and health status. Therefore, adding PT care to
GP care is only more effective regarding the primary out-
come (GPE) than GP care alone in the long-term, for the
average patient with (sub) acute sciatica. Moreover, PT
care added to GP care seemed to be especially effective
regarding GPE in the subgroup with patients reporting
more severe disability at presentation.
Strengths and limitations
Although the control group had three dropouts compared
with only one in the intervention group, this did not appear
to bias the results because all dropped-out immediately
after randomisation, and results of both the per-protocol
analysis and the intention-to-treat analysis were similar.
Table 4 Data on treatment results at 3, 6, 12 and 52 weeks after baseline: secondary outcomes
GP + PT care GP care only Mean difference
(GP + PT) - (GP) (95% CI)
Effect size
(95% CI)Improvement (n = 67) Improvement (n = 68)
Three weeks after baseline
Leg pain on NRSa,b -2.3 (2.4) -1.9 (2.4) -0.4 (-1.2; 0.4) 0.17 (-0.2; 0.5)
Back pain on NRSa,b -2.0 (2.8) -1.7 (2.4) -0.3 (-1.2; 0.6) 0.12 (-0.2; 0.5)
Six weeks after baseline
Leg pain on NRSa,b -3.0 (2.7) -3.3 (2.8) 0.3 (-0.6; 1.2) 0.11 (-0.2; 0.5)
Back pain on NRSa,b -2.3 (3.1) -2.6 (2.7) 0.3 (-0.7; 1.3) 0.19 (-0.2; 0.5)
RDQ scorec,b -5.3 (7.0) -6.6 (6.1) 1.3 (-0.9; 3.6) 0.22 (-0.1; 0.5)
General healthd,b 2.2 (16.4) -2.8 (13.9) 5.0 (0.2; 10.1) 0.36 (-0.0; 0.7)
Twelve weeks after baseline
Leg pain on NRSa,b -3.9 (2.8) -3.7 (3.1) -0.2 (-1.2; 0.8) 0.05 (-0.3; 0.4)
Back pain on NRSa,b -2.7 (3.2) -2.6 (2.9) -0.1 (-1.2; 0.9) 0.04 (-0.3; 0.4)
RDQ scorec,b -7.7 (7.3) -8.5 (6.7) 0.8 (-1.6; 3.2) 0.12 (-0.2; 0.5)
General healthd,b -1.2 (18.4) -4.7 (16.4) 3.5 (-2.4; 9.5) 0.22 (-0.1; 0.5)
Fifty-two weeks after baseline
Leg pain on NRS a b -4.4 (2.7) -3.7 (2.7) -0.7 (-1.7; 0.2) 0.26 (-0.1; 0.6)
Back pain on NRSa,b -3.0 (3.1) -2.3 (2.9) -0.7 (-1.7; 0.4) 0.23 (-0.1; 0.6)
RDQ scorec,b -10.0 (6.5) -9.1 (6.1) -0.9 (-3.0; 1.3) 0.14 (-0.2; 0.5)
TSK scoreb,e -3.3 (7.3) -4.5 (6.6) 1.2 (-1.2; 3.6) 0.17 (-0.2; 0.5)
General healthd,b -3.1 (15.7) -4.1 (16.7) 1.0 (-4.5; 6.5) 0.06 (-0.3; 0.4)
All outcome measures are presented in means and standard deviation, unless otherwise stated
a NRS Numerical rating scale. Score range from 0 (no pain) to 10 (unbearable pain)
b Negative results denote positive results for patients
c RDQ Roland disability questionnaire. Score range from 0 (no disability) to 24 (severe disability)
d Dimension of the SF-36 = Short form 36 questionnaire. Score range each dimension 0–100; higher score indicates a better health state
e TSK Tampa scale for kinesiophobia. Scores ranges from 17 to 68 points; higher score indicates more kinesiophobia
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The loss to follow-up in the study was not very high
(\20%); at 12-months follow-up 10% (n = 7) in the
intervention group and 16% (n = 11) in the control group.
In statistics the missing values were assigned the last
available score which could lead to bias towards no dif-
ferences between the treatment groups, if the loss to follow
up is (very) high. However, the per-protocol analysis and
the intention-to-treat analysis turned out to be similar.
There are no indications that not blinding GPs, physical
therapists and patients biased the results; at 12 weeks fol-
low-up the within-group improvement of both groups was
considerable for GPE, the leg pain on NRS and the RDQ.
The trial intended to enrol 182 eligible patients. Finally,
135 patients were randomised in the two treatment groups.
For practical reasons (time and money) the recruiting
period for patients could not be extended. This may have
biased the results, i.e. that the study could have underes-
timated the effect of the intervention because less patients
were randomised according to the sample size calculation.
Nevertheless, at 12-months follow-up a significant and
clinically relevant difference between both groups, in
favour of the intervention group, was found on the primary
outcome ‘GPE’.
At long-term follow-up a clinically relevant change was
found on the primary outcome measure (GPE) between the
two groups, in favour of the intervention group; the dif-
ference was 23%. A priori was stated that a clinically
relevant difference had to be at least 20% [14]. However,
recent work of Ostelo and De Vet shows the need for more
research on the exact value for the minimal clinically
important difference between two groups in this type of
study [17].
Literature
A few randomised clinical trials have evaluated PT as a
treatment for the LRS. Hofstee et al. focused on bed rest,
PT and continuation of activities of daily living [8]; their
trial included 250 patients with acute sciatica, and the
authors concluded after a 6-month follow-up period that
bed rest and PT are no more effective than continuation of
the activities of daily living [8]. Coxhead et al. compared
four methods of PT (traction, exercises, manipulation and
corset therapy) in 322 participating patients with sciatica
[3]; the authors concluded that although active PT appeared
to be of short-term value, it did not seem to confer any
long-term benefit [3]. Lidstro¨m and Zachrisson compared
three methods of PT (massage/exercises, traction and hot
packs) in 62 patients with sciatica [11]; after treatment
(1 month after randomisation) they concluded that the
traction group showed better results than the other two
groups [11]. The results of our study are not in concordance
with the earlier studies, because we found that in the long-
term PT care added to GP care is effective.
There are substantial differences between these clinical
trials regarding the study population (e.g. underlying cause
of LRS and mix of acute, subacute and chronic patients),
control treatments, duration of follow-up, and primary
outcome measures. Because of this heterogeneity it is very
difficult to compare these studies. Furthermore, the previ-
ous studies did not measure the absence from work (or did
not report on this outcome). In the present study, there were
no significant differences in absence from work between
groups at short- or long-term follow-up. The economic
evaluation alongside this randomised clinical trial is pre-
sented elsewhere [12]. Concluded was that the treatment of
patients with LRS with PT and GP care is not more cost-
effective than GP ‘care alone [12].
The results of our study indicate that PT added to GP
care was better regarding GPE but not more cost-effective
for the average patient with a LRS than GP care alone in
the long-term. Moreover, for patients with severe disability
at presentation, PT care added to GP care seemed to be
especially effective regarding GPE. Future trials are nec-
essary to evaluate the (cost-)effectiveness of PT in patients
with severe disability.
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